目的 评价腔内球囊扩张术在移除带涤纶套隧道式导管 (TCC) 嵌顿中的安全性和有效性.方法 回顾性分析2017年1月至2018年3月在浙江省台州医院接受腔内球囊扩张术治疗的4例TCC嵌顿维持性血液透析患者临床资料和影像学资料.术后监测患者生命体征, 观察有无血气胸、皮下血肿、心律失常等操作相关并发症.结果 4例TCC嵌顿患者平均年龄 (73.3±6.4) 岁, TCC平均留置时间为5.5年 (4～8年) .所有患者嵌顿移除均获成功, 其中1例接受双球囊双腔内同时扩张术.术中1例出现一过性心律失常, 术后无严重并发症发生.结论 腔内球囊扩张术移除嵌顿TCC微创、安全有效, 但仍需更多病例研究进一步证实其安全性和可靠性.%Objective To evaluate the safety and effectiveness of endovascular balloon dilatation in removing incarcerated tunnel cuffed catheter (TCC) . Methods The clinical data and the imaging materials of 4 hemodialysis patients with incarcerated TCC, who received endovascular balloon dilatation at Taizhou Hospital of Zhejiang Province, China, during the period from January 2017 to March 2018, were retrospectively analyzed. After the treatment, the patient's vital signs were monitored, and the procedure-related complications such as hemopneumothorax, subcutaneous hematoma, arrhythmia, etc. were documented. Results The mean age of the 4 patients was (73.3±6.4) years. The average indwelling time of TCC was 5.5 years (4-8 years) . Successful treatment of incarcerated TCC was achieved in all 4 patients. In one patient, both 5-mm and 6-mm balloons were used to simultaneously dilate the dual cavities of TCC.Temporary arrhythmia occurred in one patient during operation. No serious postoperative complications occurred. Conclusion For the remove of long-term indwelling incarcerated TCC, endovascular balloon dilatation is minimally-invasive, safe and effective, although more researches are needed to further confirm its safety and reliability.
展开▼
